8-K/A: NaturalShrimp Amends IP Deal, Renames to BlueFuture Aquatics

NaturalShrimp Inc. amends its intellectual property acquisition agreement, granting a perpetual license and changing its name to BlueFuture Aquatics, Inc.

Summary

• NaturalShrimp Inc. has filed an amendment (Form 8-K/A) to a previous report, clarifying terms of an Intellectual Property Acquisition and Management Transition Agreement.
• The company's legal name has been changed to BlueFuture Aquatics, Inc. effective February 11, 2026, though FINRA notification is pending.
• Instead of a full IP transfer, Hydrenesis, Inc. has granted NaturalShrimp a perpetual, worldwide, exclusive license to use its technology in aquaculture.
• NaturalShrimp will own improvements developed within the licensed field, while Hydrenesis retains ownership of the underlying technology.
• The company agreed to issue Series P preferred stock (10% economic ownership) to CEO David Antelo and Series P-2 preferred stock (15% economic ownership) to Hydrenesis.
• Additional preferred shares can be earned by Mr. Antelo and Hydrenesis upon achieving specific corporate and commercial milestones.
• If all milestones are met, Mr. Antelo and Hydrenesis could hold a combined 65% economic ownership of the company.
• A condition requiring the company's liabilities to be reduced to $1,000,000 or less was waived, but this did not settle any existing debt.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this filing as neutral; while it clarifies IP licensing and includes a name change, the significant potential dilution and continued high liabilities temper positive sentiment.

Positives

• Secured a perpetual, worldwide, exclusive license to key technology for aquaculture, ensuring long-term access.
• Company will own improvements developed on the licensed technology, fostering future innovation.
• Potential for significant future ownership stake (up to 65%) for CEO and Hydrenesis upon achievement of performance milestones, aligning incentives.
• Name change to BlueFuture Aquatics, Inc. reflects a potential strategic shift or rebranding.

Negatives

• The intellectual property transfer originally contemplated did not occur.
• Significant economic ownership (up to 65%) may transfer to CEO and Hydrenesis if milestones are met, diluting existing shareholders.
• The waiver of the liability reduction condition means the company's outstanding liabilities remain unchanged.
• Name change to BlueFuture Aquatics, Inc. has not yet been submitted to FINRA, causing potential market confusion with the existing trading symbol SHMP.

Risks

• The company's future success is heavily dependent on achieving unspecified corporate and market readiness, strategic development, commercialization, and financial performance milestones.
• If all milestones are achieved, the CEO and Hydrenesis could collectively own up to 65% of the company, significantly impacting control and dilution for existing shareholders.
• The company's existing liabilities have not been reduced as previously required, posing ongoing financial risk.
• Delays in FINRA processing the name change and new trading symbol could lead to market confusion and affect trading liquidity.

Future Outlook

The company's future outlook is contingent on achieving a series of milestones related to corporate readiness, strategic development, commercialization, and financial performance, which will determine the issuance of additional preferred stock and the ultimate economic ownership structure.

Management Comments

• The amendment confirms that the intellectual property transfer contemplated by the original agreement did not occur.
• Hydrenesis granted the Company a perpetual, worldwide, exclusive, and sublicensable license to use and commercialize the licensed technology in aquaculture and related fields.
• The Company will own any improvements it develops within the licensed field, subject to Hydrenesis's continued ownership of the underlying licensed technology.
• The parties waived the closing condition requiring the Company's remaining liabilities to be reduced to $1,000,000 or less.

Industry Context

StockSavvy.ai notes that the shift towards licensing intellectual property rather than outright acquisition is a common strategy in technology-driven industries to manage capital expenditure and risk, especially for companies focused on scaling commercialization.

Corporate Governance

Related Party Transactions

• The amendment involves CEO David Antelo and Hydrenesis, Inc. (where Mr. Antelo is CEO), concerning intellectual property licensing and preferred stock issuance.
• Former company officers Gerald Easterling, Thomas Untermeyer, and William Delgado executed the amendment in their individual capacities.

Stakeholder Impact

• Shareholders: Potential for significant dilution if performance milestones are met, leading to a substantial shift in economic ownership.
• Creditors: Existing liabilities remain unchanged, continuing to pose a financial risk.
• Management/Employees: The name change and IP licensing may signal a new strategic direction, potentially impacting future operations and roles.

Next Steps

• Notify FINRA of the name change and request a new trading symbol.
• The Company intends to submit the applicable certificates of designation for the Series P and Series P-2 Preferred Stock.
• Monitor the achievement of corporate and market readiness, strategic development, commercialization, and financial performance milestones.

Key Dates

Recommendation

The filing introduces significant potential dilution through preferred stock issuances tied to future milestones, alongside a name change. While the IP licensing is positive, the lack of liability reduction and the uncertainty surrounding milestone achievement warrant a 'hold' recommendation pending further clarity on performance and FINRA's processing of the name change.

Keywords

Aquaculture Technology, Intellectual Property License, Preferred Stock, Milestone Achievement, Corporate Governance, Name Change, Capitalization, Licensing Agreement